View prostate cancer trials »

3-Dimensional Transrectal Ultrasound for Prostate Cancer Diagnosis and Surveillance
Aims: To evaluate the impact of using a 3-dimensional transrectal ultrasound for diagnosis and surveillance of prostate cancer. Before the Food and Drug Administration (FDA) approved 3-D ultrasounds, all prostate biopsies were performed using 2-dimensional images. The 3-D technology potentially allows for better visualization to increase accuracy of needle placement when sampling different parts of the prostate. The study involves access to your medical record and does not include any additional procedures.
Diagnosis: Undergoing 3-D Prostate Biopsy
Principal Investigator: Michael McGuire, MD
IRB Approval Number: EH10-379
Sponsor: NorthShore University HealthSystem
Contact: Study Coordinator, Jackie Petkewicz at 847.503.4282
Open to Enrollment: Yes

Prostate Cancer Susceptibility: The ICPCG Study (International Consortium for Prostate Cancer Genetics)
Aims: To determine the genetic basis of prostate cancer. Families with at least two men affected with prostate cancer are likely to harbor genetic susceptibility to the disease. By studying these families, researchers may identify new genes or genetic mutations that may predispose certain men to prostate cancer or aggressive disease. The study involves a one-time blood draw and a minimal one-time questionnaire.
Diagnosis: A Family History of Prostate Cancer
Principal Investigator: Brian Helfand, MD, PhD
IRB Approval Number: EH13-250
Sponsor:  John and Carol Walter Center for Urological Health
Contact: Study Coordinators, Tina Selkirk at 847.570.4652, or Jackie Petkewicz at 847.503.4282
Open to Enrollment:
Yes

Relationship between Lower Urinary Tract Dysfunction, Sexual Function and Obstructive Sleep Apnea
Aims: To better understand the relationship between urinary tract symptoms, obstructive sleep apnea, and sexual function. We would like to determine how treatment for urinary tract symptoms affects the severity of obstructive sleep apnea symptoms and vice versa. The study involves periodic online questionnaires.
Diagnosis: Lower Urinary Tract Symptoms or Obstructive Sleep Apnea
Principal Investigator: Brian Helfand, MD, PhD
IRB Approval Number: EH13-479
Sponsor: John and Carol Walter Center for Urological Health
Contact: Study Coordinator, Jackie Petkewicz at 847.503.4282
Open to Enrollment: Yes

Qualitative Assessment of Lower Urinary Tract Dysfunction Study Protocol 1
Aims: To provide valuable information to researchers about how patients experience problems with their bladder that may affect their quality of life. We would like use this information to develop a better measurement questionnaire for urinary and bladder symptoms. The study involves a one-time interview and questionnaire.
Diagnosis: Lower Urinary Tract Symptoms
Principal Investigator: Brian Helfand, MD, PhD
IRB Approval Number: EH14-231
Sponsor: National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contact: Study Coordinator, Jasmine Nero at 847.503.3087
Open to Enrollment: Yes

A2-8796-007: Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q)
Aims: Using a new questionnaire to better evaluate and understand the quality of life of men with low testosterone. The information collected will be used to finalize this new questionnaire that will be used in later clinical trials. The study involves periodic blood collection and online questionnaires using a study-provided electronic tablet.
Diagnosis: Low Testosterone
Principal Investigator: Brian Helfand, MD, PhD
IRB Approval Number: EH14-011
Sponsor: AbbVie
Contact: Study Coordinator, Jasmine Nero at 847.503.3087
Open to Enrollment: Yes

Genomic Markers in Transitional Cell Cancer of the Bladder, Renal Pelvis and Ureter: Sample Acquisition for Methods Development and Discovery
Aims: To provide valuable information to researchers in the development of a new genetic test that that may help detect, assess risk, and guide management of these diseases in the future. The study involves a one-time blood collection and a minimal one-time urine collection.
Diagnosis: Transitional Cell Cancer or Suspected Transitional Cell Cancer
Principal Investigator: Brian Helfand, MD, PhD
IRB Approval Number: EH14-031
Sponsor: Genomic Health, Inc.
Contact: Study Coordinator, Jasmine Nero at 847.503.3087
Open to Enrollment: Yes

Mind-Body Health in Uro-Oncology
Aims: To evaluate an 8-week mind-body health program that is intended to promote wellness and improve the quality of life of patients who have been diagnosed with prostate cancer, kidney cancer, or bladder cancer (and their spouses/partners if applicable). The study involves attendance at a 8-week class, blood spot collection, and online questionnaires. See brochure »
Diagnosis: Localized or Locally-Advanced Prostate, Kidney or Bladder Cancer
Principal Investigators: Charles Brendler, MD and David Victorson, PhD
IRB Approval Number: EH13-088
Sponsor: NorthShore University HealthSystem
Contact: Study Coordinator, Nat Sufrin at 847.503.4281
Open to Enrollment: Yes

Compliance and Outcomes with Penile Rehabilitation in Men after Prostate Cancer Treatment
Aims: To determine the impact of sexual function rehabilitation on quality of life in men who have undergone prostate cancer treatment with either surgery or radiation therapy. Treatment compliance and satisfaction will be measured. The study involves periodic questionnaires.
Diagnosis: Sexual Dysfunction following Prostate Cancer Treatment 
Principal Investigator: Jeffrey Albaugh, PhD, APRN
IRB Approval Number: EH13-049
Sponsor: NorthShore University HealthSystem
Contact: Nurse Navigator, Martha McCurdy at 847.503.4245 or Study Coordinator, Nat Sufrin at 847.503.4281
Open to Enrollment: Yes

The Lived Experience of Men with Sexual Dysfunction after Prostate Cancer Treatment
Aims: To document the lived experience of men with sexual dysfunction (and their partners/spouses, if applicable) after prostate cancer treatment. This information may help both patients and health care professionals better understand the patient and partner perspective on sexual dysfunction after prostate cancer treatment. The study involves a one-time questionnaire and interview. See brochure »
Diagnosis: Sexual Dysfunction following Prostate Cancer Treatment 
Principal Investigator: Jeffrey Albaugh, PhD, APRN
IRB Approval Number: EH14-133
Sponsor: NorthShore University HealthSystem
Contact: Study Coordinator, Nat Sufrin at 847.503.4281
Open to Enrollment: Yes

× Alternate Text